Blood pressure (BP) control among the hypertensive population is notoriously poor in clinical practice. [1] [2] [3] [4] [5] [6] This has serious consequences for public health because in hypertensive patients, uncontrolled BP is associated with a high incidence of cardiovascular morbidity and fatal myocardial infarction, heart failure, and stroke. 7, 8 It is because of these factors that hypertension is the most important cause of death worldwide. 9 Relatively recent studies performed in Italy have shown that as compared with the extremely low rates observed decades ago, 10 BP control among the hypertensive population has improved [11] [12] [13] [14] [15] [16] [17] and is now comparable with that of other European countries. 3, [18] [19] [20] [21] 26 Information on how the situation has developed in the last few years is limited, however, because the available studies have variably involved patients followed up by general practitioners (GPs), specialists, or hospital outpatient centers, i.e., patients with different demographic and clinical characteristics (variable organ damage, risk factors, and total cardiovascular risk) among whom the challenges to achieve BP control differ substantially. Furthermore, studies addressing the rate of BP control in patients under the care of GPs (i.e., professionals responsible for monitoring the vast majority of hypertensive population and those best placed to provide data that would be representative of the wider community) are either regionally based 16 or involve a selected network of physicians that may not be representative of wider clinical practice. 15 The present study was undertaken in an effort to obtain updated information on the type, levels, and effectiveness of BP control in hypertensive patients under the care of GPs in Italy. Particular strengths of the study are as follows: (i) data were obtained from a large number of patients treated by a large number of physicians and (ii) recruitment criteria rendered the subject-pool likely to be a representative of the wider Italian hypertensive population.
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Methods
Data reported in this study were obtained by an observational, cross-sectional, multicenter survey of medically diagnosed hypertensive patients followed up by GPs throughout the Italian territory (stuDio Italiano sulla Gestione dell IperTensione or DIGIT). The inclusion criteria were previous original contributions Blood Pressure Control in Treated Hypertensives in Italy diagnosis of arterial hypertension and stable antihypertensive treatment at the time of the survey, whereas the exclusion criteria were refusal to participate in the study or previous participation in a clinical trial.
To increase the likelihood that the study population was representative of the wider Italian population, the GPs involved were recruited from regions throughout Italy and were asked to enroll patients on a consecutive basis. The data collected for each patient included demographic information; medical history (cardiovascular events, smoking habits, diabetes, laboratory examinations within the previous year and treatment with antidiabetic, hypolipidemic, or antihypertensive drugs); and measurement of body weight, height, and waist circumference. BP was measured by the physician by using a standard sphygmomanometer 5 min after resting the patient in the sitting position as well as after 3-5 min. The first and the fifth Korotkoff sounds were taken as the systolic and diastolic values, respectively. The second value was taken as the value representative of the visit. However, the first value was also recorded and analyzed because, although not recommended by the hypertension guidelines, 27-29 several physicians still make BP assessment based on one value only, and casual BP has been shown to be a predictor of cardiovascular morbidity and mortality. 30 A subset of patients recorded periodic self-measurements of BP at home by using a commercially available device. The data recorded by them were entered by the physician into an electronic data-sheet, which was e-mailed to the Core Database Center (G&G Medical Technologies, Rome, Italy). The identity of individual patients was masked, as required by the Italian regulations for protection of personal medical data.
The characteristics of the study population were analyzed in terms of percentages for categorical variables and means (± SD) for continuous variables. Categorical variables included controlled BP vs. uncontrolled BP, according to the guidelines of the European Society of Hypertension (ESH) and European Society of Cardiology (ESC). 28 Specifically, BP was regarded as controlled if it was <140/90 mm Hg (systolic/diastolic), except for patients with a high cardiovascular risk (mainly comprising diabetic patients in the present study) for whom the threshold for "controlled" was set at <130/80 mm Hg. For each variable, only those patients with a complete data set were included. Differences between the groups were examined for statistical significance by using nonparametric tests (χ 2 and Fisher's exact test) in the case of dichotomous variables and a parametric test (Student's t-test) in the case of continuous variables. Statistical significance was set at P < 0.05 in a two-tailed test. All analyses were performed using SAS (8th edition) statistical software for Windows (SAS Institute, Cary, NC). The study was designed and conducted in compliance with the principles of the Declaration of Helsinki.
results
A total of 8,572 treated hypertensive patients were enrolled (48.4% men and 51.6% women) by 2,643 GPs over the period between January and June 2009. The average age of the patients was 64.3 ± 10.5 years; height, 167.2 ± 8.2 cm; and weight, 76.2 ± 13.4 kg. The average body mass index of the patients was 26.7 ± 4.3 kg/m 2 (27.0 ± 3.9 kg/m 2 in men and 26.4 ± 4.7 kg/ m 2 in women), and the average waist circumference was 97.2 ± 12.2 cm (100.9 ± 10.7 cm in men and 92.3 ± 12.3 cm in women). The upper panel of Figure 1 shows that in the overall hypertensive population, average diastolic BP was 83.2 ± 7.6 mm Hg, whereas average systolic BP was 141.7 ± 14.0 mm Hg. Combined systo-diastolic BP control (i.e., BP <140/90 mm Hg) was observed in 33.5% of the surveyed population (34.2% in men and 33.4% in women), and diastolic BP control alone was almost twice as frequent as systolic BP control (P < 0.0001). The lower panel of Figure 1 shows that in diabetic patients, the original contributions
Blood Pressure Control in Treated Hypertensives in Italy
average systolic and diastolic BP values were slightly higher and lower, respectively, than those in the general hypertensive population; moreover, the stricter BP target (<130/80 mm Hg), as indicated by the ESH/ESC guidelines, 28 was achieved only by an extremely low number of patients (5.5%), with a significant (P < 0.0001) and marked difference between the systolic and diastolic BP control values. BP control was much more frequent (61.2 vs. 38.8%; P < 0.0001) in patients who performed self-BP measurements (n = 5,065). Data concerning the type of treatment were available for 8,299 patients. Of the 8,299 patients, 3,041 were treated with a single antihypertensive drug, with the most widely used drugs being angiotensin-converting-enzyme inhibitors (67.6%); 3,402 patients (40.9% of the total study population) were treated with 2 drugs, with the most widely used combination being an angiotensin-converting-enzyme inhibitor plus a diuretic (38.6%); 1,856 patients (22.3% of the total) were treated with ≥3 drugs. The respective BP control rates (<140/90 mm Hg systolic/diastolic and <130/80 mm Hg for diabetics) of these three groups were 36.6, 41.0, and 22.3%, respectively. BP was considerably higher for the first BP measurement (146.7(±15.8)/85.6(± 8.2) mm Hg; P < 0.0001 for both the systolic and diastolic BP difference), with (i) a correspondingly lower rate of systolic/diastolic BP control (27.0% of all patients; 26.9% in men and 27.7% in women) and (ii) much more frequent systolic BP control than diastolic BP control (26.9 vs. 56.9%, P < 0.0001) and lower control in diabetic patients (4.4%). Figure 2 shows the additional cardiovascular risk factors recorded in the surveyed hypertensive population, whereas Figure 3 shows the diagnostic examinations obtained in the previous year. A multifactorial risk profile was common, with obesity being the single most common risk factor. A standard electrocardiogram was the most frequently obtained examination (93.8%), followed by an echocardiogram, and a carotid artery ultrasonography. A 24-h ambulatory BP monitoring was available to less than one-third of the study population (26.6%). In 16.6% of the patients, dynamic electrocardiogram monitoring data, i.e., an examination which is not a part of the diagnostic and follow-up recommendations of the ESH/ESC guidelines on hypertension, 28 was available.
discussion
Our 2009 survey of a large number of Italian hypertensive patients treated by GPs provides three main sets of data. First, in the total study population, average diastolic BP values were well below 90 mm Hg, whereas the average systolic BP values were above 140 mm Hg. Second, patients in whom BP was controlled according to the ESH/ESC guidelines (140/90 mm Hg) 28 represented only ~33% of the surveyed population, with a pronounced difference between low systolic and higher diastolic BP control. Third, in diabetic patients, the stricter BP control recommended by these guidelines (<130/80 mm Hg) was observed in only 5.5% of cases. This allows us to conclude that in a real-life setting such as that represented by hypertensive patients treated by GPs, BP control remains unsatisfactory, largely because of the inability to effectively reduce systolic BP. Furthermore, achievement of a stricter BP control recommended by the ESH/ESC guidelines for diabetic patients is extremely rare, therefore virtually depriving the guideline recommendations on BP values to be reached with treatment in this group of a practical reflection.
When the initial BP measurement was considered, average BP values were noticeably higher (5.0 and 2.4 mm Hg for systolic and diastolic BP, respectively) and the percentage of patients with BP control was lower (−6.5%) than that during analyses with the second measurement. This finding (that originates from an alerting reaction of the patient to the BP measuring procedure) 31,32 is of interest not only because a large number of physicians still make BP assessment by using a single measurement but also because it emphasizes that comparisons between studies are open to errors unless data are derived from standardized BP measurements. With few exceptions, 33, 34 this is usually not the case. Moreover, standardization should include the timing of BP measurements, given that the alerting-induced increase in BP persists for up to 10 min after the initial peak. 31, 32 It is possible that in our study a further reduction of absolute mean BP values and increase in the percentage of patients with BP control would have been observed if BP measurements had been performed after a further 5 min. original contributions
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The abovementioned considerations represent further limitations to the reliability of comparisons between our study and other studies that have assessed the rate of BP control in Italian hypertensive patients in the more recent past (see Introduction). Although BP was measured using a different method, the most reliable comparison is that with a large GP-based study performed throughout the Italian territory in 2005 in which the BP target was achieved in 43.7% of the treated hypertensive population and 4.6% in the diabetic population. 11 Therefore, a conservative conclusion could be that it is unlikely that BP control among Italian hypertension patients has improved in the recent years.
Several other results are noteworthy. First, BP was not controlled in ~63% of patients under monotherapy. Therefore, the recommendation of international guidelines 27, 28 that if 1 antihypertensive drug is not effective, other drugs should be added to take advantage of the superior BP-lowering properties of combination treatment, 35 is insufficiently implemented in clinical practice. It should be emphasized that this is not in contrast with the findings that BP remained frequently uncontrolled when ≥2 drugs were administered; physicians may preferentially use ≥2 drugs in patients with more severe hypertension, risk factors, and/or organ damage because in such patients, BP control is more difficult. 12 , [22] [23] [24] [25] [26] Second, in the subgroup of patients who performed self-BP measurements at home, the rate of BP control was much higher than that in the subgroup of patients who did not adopt this procedure. This extends to the real-life setting, evidence that self-BP measurement favors treatment-induced BP reductions and in general plays a favorable therapeutic role 36, 37 presumably by improving compliance to treatment. 38 Indeed, the difference in BP control between patients with and without self-BP measurement was so large to suggest that this procedure may be associated with substantial advantages, and therefore, its routine adoption should be pursued. Third, our patients showed a relatively high prevalence of cardiovascular risk factors other than hypertension-related factors. This is in accordance with previous studies 13, 14 that have shown that even in Mediterranean countries, patients with elevated BP frequently show a multifactorial cardiovascular risk profile. Further, it shows that an overall high cardiovascular risk is by no means a characteristic of patients under specialist care but is rather a characteristic of hypertensive patients under GP care as well. This is further suggested by the frequent availability of dynamic electrocardiogram monitoring data, which may be derived in part from the diagnostic suspicion of an associated coronary disease.
Finally, our study does not clarify the reasons why BP control remains low in Italian hypertensive patients under GP care. However, it is likely that a large number of factors may be involved. Studies have identified inertia of physicians (i.e., no treatment modification when BP is found to be uncontrolled), [39] [40] [41] [42] poor patient compliance with the prescribed treatment regimen, [43] [44] [45] and difficulties inherent to healthcare systems (such as delayed visits, distance from pharmacies where drugs are available, and cost of drugs) as contributory factors. [46] [47] [48] We can speculate that in Italy, poor compliance to treatment is of paramount importance. This is because analysis of the administrative database of the most highly populated Italian region (Lombardy) showed that ~70% of the hypertensive population failed to renew their prescription for medication after it had expired, which had a major effect on the incidence of hospitalization for cardiovascular disease. 49, 50 Our study provides information on how often the instrumental examinations recommended by the ESH/ESC guidelines 28 were performed in hypertensive patients. Perhaps the most interesting finding is that these examinations rarely include ambulatory BP monitoring, which thus represents a potential source of information that is under-utilized by Italian GPs. This suggests that the recommendation that diagnosis of hypertension requires automated BP recording over the daytime (see the guidelines on hypertension issued in UK by the National Institute for Clinical Excellence) 51 , in addition to being based on questionable evidence 52 may have a limited chance of rapid implementation in clinical practice.
In conclusion, our study on a large number of treated hypertensive patients under GP care showed that the target BP control recommended by the ESH/ESC guidelines (<140/90 mm Hg) remains low. Further, the stricter values recommended for high cardiovascular risk individuals, such as those with diabetes (<130/80 mm Hg), were only achieved in an extremely low proportion of patients. This emphasizes the need for physicians to be more vigilant and proactive in treating hypertensive patients and that further research is needed to identify strategies that can improve patient-adherence to treatment.
